ASSAY FOR DISTINGUISHING BETWEEN SEPSIS AND SYSTEMIC INFLAMMATORY RESPONSE SYNDROME
3 Assignments
0 Petitions
Accused Products
Abstract
There is provided a method for distinguishing between sepsis and systemic inflammatory response syndrome (SIRS) in a patient, comprising: (i) determining the amount of one or more biomarker for sepsis, and one or more biomarker for SIRS in a sample obtained from a patient, wherein the one or more biomarker for sepsis is selected from the group consisting of: ITGB3, ITGA2B, MYL9, LCN2, TREML1, LCN15, CMTMS, PPBP, and PF4; and the one or more biomarker for SIRS is selected from the group consisting of: PLA2G7, ARHGEF10L, MYCL, TGFBI, and GPR124, (ii) comparing the amount of the one or more biomarker for sepsis determined in said sample in (i) to a corresponding reference value representative of a healthy individual, (iii) comparing the amount of the one or more biomarker for SIRS determined in said sample in (i) to a corresponding reference value representative of a healthy individual; wherein the patient is diagnosed as having sepsis, when an increase is observed in the one or more biomarker for sepsis, and no increase is observed in the one or more biomarker for SIRS, in the sample obtained from the patient relative to the corresponding reference value; and wherein the patient is diagnosed as having SIRS, when an increase is observed in the one or more biomarker for SIRS, and no increase is observed in the one or more biomarker for sepsis, in the sample obtained from the patient relative to the corresponding reference value.
0 Citations
51 Claims
-
1-13. -13. (canceled)
-
14. A method for diagnosing whether a patient has a systemic inflammatory condition, comprising:
-
(i) determining the amount of FAM20A and OLAH in a sample obtained from a patient, (ii) comparing the amount of FAM20A determined in said sample in (i) to a corresponding reference value representative of a healthy individual, (iii) comparing the amount of OLAH determined in said sample in (i) to a corresponding reference value representative of a healthy individual; wherein the patient is diagnosed as having a systemic inflammatory condition, when an increase is observed in FAM20A and/or OLAH in the sample obtained from the patient relative to the corresponding reference value; and wherein the patient is diagnosed as not having a systemic inflammatory condition, when no increase is observed in FAM20A and OLAH, in the sample obtained from the patient relative to the corresponding reference value. - View Dependent Claims (39, 40, 41, 42, 43, 44, 49, 50, 51)
-
-
15-38. -38. (canceled)
-
45-48. -48. (canceled)
Specification